Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antifungal Prophylaxis of Invasive Fungal Infections”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Large-scale testing (Phase 3)UnknownNCT01974375
What this trial is testing

Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients

Who this might be right for
Liver Transplant Recipient
Asan Medical Center 172
Post-approval studies (Phase 4)Study completedNCT01200355
What this trial is testing

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Memorial Sloan Kettering Cancer Center 113
Testing effectiveness (Phase 2)Study completedNCT01615809
What this trial is testing

Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia

Who this might be right for
Invasive Pulmonary AspergillosisLymphoblastic LeukaemiaMyeloblastic Leukaemia+2 more
Fundació Sant Joan de Déu 32
Testing effectiveness (Phase 2)Study completedNCT01249820
What this trial is testing

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

Who this might be right for
LeukemiaMyelodysplastic SyndromeLeukemia, Myeloid, Acute
Radboud University Medical Center 26
Not applicableStudy completedNCT02127788
What this trial is testing

Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology

Who this might be right for
Antifungal ProphylaxisHaemopathy
Astellas Pharma S.A.S. 150
Early research (Phase 1)Study completedNCT00005912
What this trial is testing

Voriconazole to Prevent Systemic Fungal Infections in Children

Who this might be right for
AspergillosisCandidiasisFungal Diseases+1 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Looking for participantsNCT07215273
What this trial is testing

Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections

Who this might be right for
Suspected Invasive Mould Infection
Elion Therapeutics, Inc. 80
Testing effectiveness (Phase 2)UnknownNCT00451711
What this trial is testing

Intermittent Liposomal Amphotericin B Primary Prophylaxis

Who this might be right for
Acute Myeloid Leukemia
Bayside Health 60
Large-scale testing (Phase 3)Study completedNCT00001937
What this trial is testing

Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

Who this might be right for
AspergillosisCandidiasisFungemia+1 more
National Cancer Institute (NCI) 800
Large-scale testing (Phase 3)Study completedNCT00289991
What this trial is testing

Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)

Who this might be right for
Antifungal Prophylaxis of Invasive Fungal Infections
Pfizer 489
Testing effectiveness (Phase 2)WithdrawnNCT02856178
What this trial is testing

Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients

Who this might be right for
Pulmonary Aspergillosis - InvasiveAcute Myeloid Leukemia
F2G Biotech GmbH
Large-scale testing (Phase 3)Study completedNCT00904995
What this trial is testing

Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis

Who this might be right for
LeukemiaFungal Infection
M.D. Anderson Cancer Center 23
Not applicableUnknownNCT05130723
What this trial is testing

Pharmacokinetics of Fluconazole in Children (2-18 Years)

Who this might be right for
Invasive Fungal Infections
Radboud University Medical Center 30
Early research (Phase 1)Ended earlyNCT05534529
What this trial is testing

Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age

Who this might be right for
Invasive Fungal Infections
Mundipharma Research Limited 32
Post-approval studies (Phase 4)Ended earlyNCT01282879
What this trial is testing

Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients

Who this might be right for
Graft vs Host Disease
Samsung Medical Center 36
Testing effectiveness (Phase 2)UnknownNCT01260974
What this trial is testing

Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients

Who this might be right for
FungemiaMycoses
Azienda Ospedaliera di Padova 38
Large-scale testing (Phase 3)Active Not RecruitingNCT04368559
What this trial is testing

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
CandidemiaMycosesFungal Infection+7 more
Mundipharma Research Limited 602
Early research (Phase 1)Study completedNCT01075984
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)

Who this might be right for
Fungal Infection
Merck Sharp & Dohme LLC 279
Not applicableLooking for participantsNCT07135778
What this trial is testing

Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients With Malignant Hematological Diseases

Who this might be right for
Invasive Fungal Disease
Institute of Hematology & Blood Diseases Hospital, China 36
Testing effectiveness (Phase 2)Study completedNCT02172768
What this trial is testing

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease

Who this might be right for
Acute Graft Versus Host Disease Grade II-IVAllogeneic Stem Cell TransplantAcute Myeloid Leucaemia+1 more
Radboud University Medical Center 30
Load More Results